To provide long term capital appreciation.
Name | % Net Assets |
---|---|
ROCHE HLDG GENUSSCHEINE | 5.2% |
VIVENDI | 3.9% |
STATOILHYDRO ASA | 3.7% |
ASTRAZENECA PLC | 3.2% |
ROYAL KPN N.V. | 2.8% |
KONINKLIJKE KPN NV | 2.6% |
FRESENIUS MEDICAL CARE AG & CO.KGAA | 2.5% |
MUNCHENER RUCKVERSICHERUNGS AG | 2.4% |
SWISSCOM AG | 2.3% |
AIR LIQUIDE(L`) | 2.2% |
Key | % Net Assets |
---|---|
ROCHE HLDG GENUSSCHEINE | 5.2% |
VIVENDI | 3.9% |
STATOILHYDRO ASA | 3.7% |
ASTRAZENECA PLC | 3.2% |
Other | 84% |
Date | 21-Nov-2024 |
---|---|
NAV | 267.88p |
Currency | GBP |
Change | -1.76p |
% | -0.65% |
YTD change | 0.16p |
YTD % | 0.06% |
Fund Inception | 19/02/2001 |
---|---|
Fund Manager | Julie Quinn |
TER | 0.85 (31-Jan-2013) |
Minimum Investment | |
---|---|
Initial | £500000 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.11 |
You are here: research